Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Activist Investor Starboard Value Takes $1B Stake in Pfizer
Pfizer CEO plans to meet activist investor Starboard Value, FT reports
Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing people familiar with the matter.
Activist Starboard Value has $1 billion Pfizer stake, taps former executives for help, sources say
Starboard Value has amassed a roughly $1 billion stake in drugmaker Pfizer, according to people familiar with the matter. The activist fund run by Jeff Smith is looking to tap former Pfizer CEO Ian Read and ex-finance chief Frank D'Amelio,
Activist Investor Starboard Carves $1B Stake in Pfizer, Enlists Former CEO for Help
Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its COVID-19 products.
35m
Pfizer CEO Albert Bourla Set To Meet Activist Investor Starboard Value As Pressure Mounts To Revitalize Struggling Stock: Report
Pfizer Inc. CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the ...
5h
Pfizer CEO Albert Bourla expected to meet with activist Starboard next week - FT
Pfizer CEO is set to meet with activist investor Starboard Value after the investor acquired a $1 billion stake in the ...
1d
Meet Jeff Smith, the hedge-fund investor taking on Pfizer
Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary ...
1h
Pfizer CEO’s job is at risk. A shot of discipline could help.
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Pfizer
Ian Read
The Wall Street Journal
Feedback